AI Optics Inc.

AI Optics Inc. specializes in advanced diagnostic solutions for eye health, focusing on innovative imaging technologies to enhance the accuracy of ocular disease diagnosis. Founded in 2020 in New York, US, AI Optics Inc. develops diagnostic solutions for eye health.

The firm has raised a total of USD 14. 718 mn in funding, with the most recent round occurring in August 2025, which raised USD 14. 72 mn. The company has completed one deal to date under its current business strategy.

AI Optics specializes in innovative diagnostic solutions for eye health, primarily through its flagship products, the Sentinel Camera and the upcoming Sentinel Pro. The FDA-cleared Sentinel Camera utilizes proprietary optical technology to capture high-resolution digital images of the human eye, aimed at enhancing the visual diagnosis of various ocular diseases. The Sentinel Pro, still in investigational use, will incorporate AI-driven screening software designed to diagnose retinal conditions such as Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma. The products are designed to be user-friendly, easily implementable, and affordable, addressing significant barriers to accessing specialist eye care, particularly in primary care settings.

AI Optics targets healthcare providers across various markets, focusing on primary care, optometry, retail health, and long-term care sectors in North America and Europe, aiming to provide comprehensive eye care solutions globally. AI Optics generates revenue primarily through direct sales of its imaging hardware and software solutions to healthcare providers and institutions. The transactional structure typically involves B2B sales agreements, where clinics and health systems purchase the Sentinel Camera and, potentially in the future, subscriptions for the AI screening software associated with the Sentinel Pro. Revenue is expected to derive from one-time equipment sales, along with ongoing revenue from service contracts or software updates.

Clients, including primary care providers and specialty clinics, benefit from bundled offerings that include training and support services, enhancing the overall value proposition of the company's products. Specific pricing details for the Sentinel Camera and future offerings have not been disclosed, ensuring a focused approach to market penetration without revealing competitive pricing strategies. AI Optics plans to leverage the USD 14. 72 million raised in August 2025 to support the development and launch of the Sentinel Pro, as well as to expand operations into new geographic regions, specifically targeting additional markets within North America and Europe.

The company anticipates launching the Sentinel Pro in the near future, which will enhance its product offerings and cater to a broader range of ocular conditions. This strategic funding will also support marketing efforts and establish partnerships with healthcare providers to facilitate the introduction of its solutions into new healthcare settings.